Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lucas Basler
Observed names:
Basler, Lucas,
L. Basler
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
University of Zurich,
Board of the Swiss Federal Institutes of Technology,
Paul Scherrer Institute,
University Hospital Zurich,
Kantonsspital Aarau,
University of Tübingen
show all 6
ORCID:
0000-0003-1259-5825
Observed ORCID:
0000-0003-1259-5825
OpenAlex ID:
A5077585649
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
2020
·
Lucas Basler
, Hubert S. Gabryś
, et al.
·
Clinical Cancer Research
·
125
PDF
SBRT for oligoprogressive oncogene addicted NSCLC
2017
·
L. Basler
, S.G.C. Kroeze
, et al.
·
Lung Cancer
·
60
A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy
2020
·
Wonmo Sung
, Clemens Grassberger
, et al.
·
Radiotherapy and Oncology
·
54
PDF
Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study
2018
·
L. Basler
, N. Andratschke
, et al.
·
Radiation Oncology
·
53
PDF
Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition
2022
·
Ken Kudura
, Lucas Basler
, et al.
·
Cancers
·
24
PDF
Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy
2020
·
Lucas Basler
, Robert Poel
, et al.
·
Radiation Oncology
·
24
PDF
Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries
2019
·
S. G. C. Kroeze
, C. Fritz
, et al.
·
Strahlentherapie und Onkologie
·
23
Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging
2021
·
Carol Oliveira
, Florian Amstutz
, et al.
·
EJNMMI Research
·
20
PDF
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients
2021
·
Ken Kudura
, Florentia Dimitriou
, et al.
·
Cancers
·
19
PDF
Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma – Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes
2021
·
Marta Bogowicz
, Matea Pavic
, et al.
·
Frontiers in Oncology
·
19
PDF
Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model
2018
·
Lucas Basler
, Aleksandra Kowalczyk
, et al.
·
Cancer Immunology Immunotherapy
·
17
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
2022
·
H. S. Gabryś
, L. Basler
, et al.
·
Frontiers in Oncology
·
11
Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients
2022
·
Ken Kudura
, Lukas Nussbaumer
, et al.
·
Biomedicines
·
11
PDF
Impact of Low-Dose Irradiation of the Lung and Heart on Toxicity and Pulmonary Function Parameters after Thoracic Radiotherapy
2020
·
Christina Schröder
, André Buchali
, et al.
·
Cancers
·
10
PDF
NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors
2022
·
Christina Schröder
, Andreas Köthe
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
9
PDF
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition
2022
·
Simon Burgermeister
, Hubert S. Gabryś
, et al.
·
Frontiers in Oncology
·
6
PDF
Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
2021
·
Ken Kudura
, Florentia Dimitriou
, et al.
·
Diagnostics
·
6
PDF
NTCP Modelling for High Grade Temporal Radio-Necrosis in a Large Cohort of Patients Receiving PBS Proton Therapy for Skull Base and Head and Neck Tumors
2021
·
C. Schroeder
, A. Köthe
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Delta-radiomics for prediction of pseudoprogression in malignant melanoma treated with immune checkpoint inhibition.
2019
·
Lucas Basler
, Hubert Gabrys
, et al.
·
Journal of Clinical Oncology
·
1
Figure S3 from Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
2023
·
Lucas Basler
, Hubert S. Gabryś
, et al.
Table S1 from Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
2023
·
Lucas Basler
, Hubert S. Gabryś
, et al.
Table S3 from Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
2023
·
Lucas Basler
, Hubert S. Gabryś
, et al.
Figure S2 from Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
2023
·
Lucas Basler
, Hubert S. Gabryś
, et al.
PDF
Table S2 from Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
2023
·
Lucas Basler
, Hubert S. Gabryś
, et al.
Figure S1 from Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
2023
·
Lucas Basler
, Hubert S. Gabryś
, et al.
PDF
Show more works
View as search
Works count:
48
Citation count:
493
H-index:
11
I10-index:
14
Year
Topic
Type